Neurologic Disorders Therapeutics Market Status and Trend Analysis 2017-2026 (COVID-19 Version)
SUMMARY
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Neurologic Disorders Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Neurologic Disorders Therapeutics market segmented into
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Neurologic Disorders Therapeutics market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Neurologic Disorders Therapeutics market segmented into
- Central Nervous System (CNS)
- Peripheral Nervous System (PNS)
- Paralysis
- Muscle Weakness
- Poor Coordination
- Loss of Sensation
- Seizures
- Confusion
- Pain and Altered Levels of Consciousness
- North America [U.S., Canada, Mexico]
- Europe [Germany, UK, France, Italy, Rest of Europe]
- Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
- South America [Brazil, Argentina, Rest of Latin America]
- Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
- Biogen Inc.
- F. Hoffmann-La Roche Ltd.
- Johnson & Johnson Services Inc.
- Novartis AG
- Pfizer Inc.
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NEUROLOGIC DISORDERS THERAPEUTICS INDUSTRY
2.1 Summary about Neurologic Disorders Therapeutics Industry
2.2 Neurologic Disorders Therapeutics Market Trends
2.2.1 Neurologic Disorders Therapeutics Production & Consumption Trends
2.2.2 Neurologic Disorders Therapeutics Demand Structure Trends
2.3 Neurologic Disorders Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Central Nervous System (CNS)
4.2.2 Peripheral Nervous System (PNS)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Paralysis
4.3.2 Muscle Weakness
4.3.3 Poor Coordination
4.3.4 Loss of Sensation
4.3.5 Seizures
4.3.6 Confusion
4.3.7 Pain and Altered Levels of Consciousness
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Central Nervous System (CNS)
5.2.2 Peripheral Nervous System (PNS)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Paralysis
5.3.2 Muscle Weakness
5.3.3 Poor Coordination
5.3.4 Loss of Sensation
5.3.5 Seizures
5.3.6 Confusion
5.3.7 Pain and Altered Levels of Consciousness
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Central Nervous System (CNS)
6.2.2 Peripheral Nervous System (PNS)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Paralysis
6.3.2 Muscle Weakness
6.3.3 Poor Coordination
6.3.4 Loss of Sensation
6.3.5 Seizures
6.3.6 Confusion
6.3.7 Pain and Altered Levels of Consciousness
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Central Nervous System (CNS)
7.2.2 Peripheral Nervous System (PNS)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Paralysis
7.3.2 Muscle Weakness
7.3.3 Poor Coordination
7.3.4 Loss of Sensation
7.3.5 Seizures
7.3.6 Confusion
7.3.7 Pain and Altered Levels of Consciousness
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Central Nervous System (CNS)
8.2.2 Peripheral Nervous System (PNS)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Paralysis
8.3.2 Muscle Weakness
8.3.3 Poor Coordination
8.3.4 Loss of Sensation
8.3.5 Seizures
8.3.6 Confusion
8.3.7 Pain and Altered Levels of Consciousness
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Central Nervous System (CNS)
9.2.2 Peripheral Nervous System (PNS)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Paralysis
9.3.2 Muscle Weakness
9.3.3 Poor Coordination
9.3.4 Loss of Sensation
9.3.5 Seizures
9.3.6 Confusion
9.3.7 Pain and Altered Levels of Consciousness
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Biogen Inc.
10.1.2 F. Hoffmann-La Roche Ltd.
10.1.3 Johnson & Johnson Services Inc.
10.1.4 Novartis AG
10.1.5 Pfizer Inc.
10.2 Neurologic Disorders Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Biogen Inc.
10.2.2 F. Hoffmann-La Roche Ltd.
10.2.3 Johnson & Johnson Services Inc.
10.2.4 Novartis AG
10.2.5 Pfizer Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL NEUROLOGIC DISORDERS THERAPEUTICS INDUSTRY
2.1 Summary about Neurologic Disorders Therapeutics Industry
2.2 Neurologic Disorders Therapeutics Market Trends
2.2.1 Neurologic Disorders Therapeutics Production & Consumption Trends
2.2.2 Neurologic Disorders Therapeutics Demand Structure Trends
2.3 Neurologic Disorders Therapeutics Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Central Nervous System (CNS)
4.2.2 Peripheral Nervous System (PNS)
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Paralysis
4.3.2 Muscle Weakness
4.3.3 Poor Coordination
4.3.4 Loss of Sensation
4.3.5 Seizures
4.3.6 Confusion
4.3.7 Pain and Altered Levels of Consciousness
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Central Nervous System (CNS)
5.2.2 Peripheral Nervous System (PNS)
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Paralysis
5.3.2 Muscle Weakness
5.3.3 Poor Coordination
5.3.4 Loss of Sensation
5.3.5 Seizures
5.3.6 Confusion
5.3.7 Pain and Altered Levels of Consciousness
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Central Nervous System (CNS)
6.2.2 Peripheral Nervous System (PNS)
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Paralysis
6.3.2 Muscle Weakness
6.3.3 Poor Coordination
6.3.4 Loss of Sensation
6.3.5 Seizures
6.3.6 Confusion
6.3.7 Pain and Altered Levels of Consciousness
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Central Nervous System (CNS)
7.2.2 Peripheral Nervous System (PNS)
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Paralysis
7.3.2 Muscle Weakness
7.3.3 Poor Coordination
7.3.4 Loss of Sensation
7.3.5 Seizures
7.3.6 Confusion
7.3.7 Pain and Altered Levels of Consciousness
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Central Nervous System (CNS)
8.2.2 Peripheral Nervous System (PNS)
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Paralysis
8.3.2 Muscle Weakness
8.3.3 Poor Coordination
8.3.4 Loss of Sensation
8.3.5 Seizures
8.3.6 Confusion
8.3.7 Pain and Altered Levels of Consciousness
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Central Nervous System (CNS)
9.2.2 Peripheral Nervous System (PNS)
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Paralysis
9.3.2 Muscle Weakness
9.3.3 Poor Coordination
9.3.4 Loss of Sensation
9.3.5 Seizures
9.3.6 Confusion
9.3.7 Pain and Altered Levels of Consciousness
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Biogen Inc.
10.1.2 F. Hoffmann-La Roche Ltd.
10.1.3 Johnson & Johnson Services Inc.
10.1.4 Novartis AG
10.1.5 Pfizer Inc.
10.2 Neurologic Disorders Therapeutics Sales Date of Major Players (2017-2020e)
10.2.1 Biogen Inc.
10.2.2 F. Hoffmann-La Roche Ltd.
10.2.3 Johnson & Johnson Services Inc.
10.2.4 Novartis AG
10.2.5 Pfizer Inc.
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
LIST OF TABLES
1.Table Neurologic Disorders Therapeutics Product Type Overview
2.Table Neurologic Disorders Therapeutics Product Type Market Share List
3.Table Neurologic Disorders Therapeutics Product Type of Major Players
4.Table Brief Introduction of Biogen Inc.
5.Table Brief Introduction of F. Hoffmann-La Roche Ltd.
6.Table Brief Introduction of Johnson & Johnson Services Inc.
7.Table Brief Introduction of Novartis AG
8.Table Brief Introduction of Pfizer Inc.
9.Table Products & Services of Biogen Inc.
10.Table Products & Services of F. Hoffmann-La Roche Ltd.
11.Table Products & Services of Johnson & Johnson Services Inc.
12.Table Products & Services of Novartis AG
13.Table Products & Services of Pfizer Inc.
14.Table Market Distribution of Major Players
15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
17.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
18.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
19.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
20.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
1.Table Neurologic Disorders Therapeutics Product Type Overview
2.Table Neurologic Disorders Therapeutics Product Type Market Share List
3.Table Neurologic Disorders Therapeutics Product Type of Major Players
4.Table Brief Introduction of Biogen Inc.
5.Table Brief Introduction of F. Hoffmann-La Roche Ltd.
6.Table Brief Introduction of Johnson & Johnson Services Inc.
7.Table Brief Introduction of Novartis AG
8.Table Brief Introduction of Pfizer Inc.
9.Table Products & Services of Biogen Inc.
10.Table Products & Services of F. Hoffmann-La Roche Ltd.
11.Table Products & Services of Johnson & Johnson Services Inc.
12.Table Products & Services of Novartis AG
13.Table Products & Services of Pfizer Inc.
14.Table Market Distribution of Major Players
15.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
16.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
17.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) by Region 2021f-2026f
18.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) Share by Region 2021f-2026f
19.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) by Demand 2021f-2026f
20.Table Global Neurologic Disorders Therapeutics Market Forecast (Million USD) Share by Demand 2021f-2026f
LIST OF FIGURES
1.Figure Global Neurologic Disorders Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Neurologic Disorders Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Neurologic Disorders Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Neurologic Disorders Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Neurologic Disorders Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Neurologic Disorders Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Neurologic Disorders Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Poor Coordination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Loss of Sensation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Seizures Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Confusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Pain and Altered Levels of Consciousness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Poor Coordination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Loss of Sensation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Seizures Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Confusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Pain and Altered Levels of Consciousness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Poor Coordination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Loss of Sensation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Seizures Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Confusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Pain and Altered Levels of Consciousness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Poor Coordination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Loss of Sensation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Seizures Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Confusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Pain and Altered Levels of Consciousness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Poor Coordination Segmentation Market Size (USD
1.Figure Global Neurologic Disorders Therapeutics Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Neurologic Disorders Therapeutics Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Neurologic Disorders Therapeutics Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Neurologic Disorders Therapeutics Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Neurologic Disorders Therapeutics Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Neurologic Disorders Therapeutics Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Neurologic Disorders Therapeutics Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure Poor Coordination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure Loss of Sensation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure Seizures Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Confusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Pain and Altered Levels of Consciousness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure Poor Coordination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure Loss of Sensation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Seizures Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Confusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Pain and Altered Levels of Consciousness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Poor Coordination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Loss of Sensation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Seizures Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Confusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Pain and Altered Levels of Consciousness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure Poor Coordination Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure Loss of Sensation Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure Seizures Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure Confusion Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure Pain and Altered Levels of Consciousness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Central Nervous System (CNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Peripheral Nervous System (PNS) Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure Paralysis Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure Muscle Weakness Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Poor Coordination Segmentation Market Size (USD
